Reply by Authors

J Urol. 2018 May;199(5):1353-1354. doi: 10.1016/j.juro.2017.11.138. Epub 2018 Feb 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Transitional Cell*
  • Humans
  • Prognosis
  • Programmed Cell Death 1 Receptor
  • Urologic Neoplasms*

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor